Abstract
Background Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of complications and death following surgery. Pulmonary complications are particularly prominent. Pulmonary rehabilitation is a course of physical exercise and education that helps people with COPD manage their condition. Although proven to improve health outcomes in patients with stable COPD, it has never been formally tested as a pre-surgical intervention in patients scheduled for non-cardiothoracic surgery. If a beneficial effect were to be demonstrated, pulmonary rehabilitation for pre-surgical patients with COPD might be rapidly implemented across the National Health Service, as pulmonary rehabilitation courses are already well established across much of the United Kingdom (UK).
Methods We performed a feasibility study to test study procedures and barriers to identification and recruitment to a randomised controlled trial testing whether pulmonary rehabilitation, delivered before major abdominal surgery in a population of people with COPD, would reduce the incidence of post-operative pulmonary complications. This study was run in two UK centres (Oxford and Newcastle upon Tyne).
Results We determined that a full randomised controlled trial would not be feasible, due to failure to identify and recruit participants. We identified an unmet need to identify more effectively patients with COPD earlier in the surgical pathway. Service evaluations suggested that barriers to identification and recruitment would likely be the same across other UK hospitals.
Conclusions Although pulmonary rehabilitation is a potentially beneficial intervention to prevent post-operative pulmonary complications, a randomised controlled trial is unlikely to recruit sufficient participants to answer our study question conclusively at the present time, when spirometry is not automatically conducted in all patients planned for surgery. As pulmonary rehabilitation is a recommended treatment for all people with COPD, alternative study methods combined with earlier identification of candidate patients in the surgical pathway should be considered.
Trial registration ISRCTN 29696295, http://www.isrctn.com/ISRCTN29696295, registered 31st August 2017
Competing Interest Statement
LM, AL, EH, JDY, NR, CS, KP no competing interests MS reports personal fees from GSK, Boehringer Ingelheim, and Nutricia, non-financial support from Boehringer Ingelheim, GSK, outside the submitted work MG received programmed activities for their role in the NELA Project Team, is a medical adviser for Sphere Medical Ltd and director of Oxygen Control Systems Ltd and received an honorarium and travel expenses from Edwards Lifesciences in 2016
Clinical Trial
ISRCTN 29696295
Funding Statement
This study was supported by the UK National Institute for Health Research, Research for Patient Benefit Scheme (grant number PB-PG-1215-20040). KP is supported by the National Institute for Health Research Biomedical Research Centre based at the University of Oxford and Oxford University Hospitals NHS Foundation Trust.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Data Availability
not applicable
